Clinical Trials Sponsored by Bioretec Ltd.

Total 16909 results

Panacea Biotec Ltd

Completed

Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fed Condition

Healthy Volunteers

India
Panacea Biotec Ltd

Completed

Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fasting Condition

Healthy Volunteers

India
Thomas Klestil
Bioretec Ltd.

Recruiting

Bioresorbable Intramedullary Nailing of Forearm Fractures (BRINFF)

Forearm Fracture

Denmark, Austria, France, Germany, Hungary, Portugal, Switzerland
Panacea Biotec Ltd

Unknown

Study Of Single Ascending Doses Of PBL 1427 In Healthy Volunteers

Diabetes Mellitus

India
Panacea Biotec Ltd

Completed

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fasting Condition

Healthy Volunteers

India
Panacea Biotec Ltd

Completed

Bioequivalence Study of Cyclosporine 100mg Capsule Under Fasting Condition

Healthy Volunteers

India
Panacea Biotec Ltd

Completed

Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fed Condition

Healthy Volunteers

India
Panacea Biotec Ltd

Completed

To Evaluate the Dose Response of 3 Doses of Euphorbia Prostrata in Patients With First and Second Degree Hemorrhoids

Hemorrhoids

India
Panacea Biotec Ltd

Completed

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition

Healthy Volunteers

India
Panacea Biotec Ltd

Completed

Bioequivalence Study of Cyclosporine 100mg Capsule Under Fed Condition

Healthy Volunteers

India
Panacea Biotec Ltd

Completed

Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fasting Condition

Healthy Volunteers

India
Jaakko Sinikumpu
Oulu University Hospital; Bioretec Ltd.

Completed

Biodegradable Versus Titanium Nailing in Forearm Shaft Fractures in Children

Forearm Fracture

Finland
Vilnius University
Biolitec Pharma Ltd.

Unknown

Randomized Trial :Hemorrhoidal Pedicle Ligation vs Laser vs Open Hemorrhoidectomy

Hemorrhoids Second Degree | Hemorrhoids Third Degree

Lithuania
BioRegen Biomedical (CHangzhou) Co., Ltd

Completed

The Efficacy and Safety Study of a New Cross-linked Hyaluronan Hydrogel in the Reduction of Postsurgical Peritoneal Adhesions (BAP)

Adhesions | Myomas | Ovary Cysts | Endometriotic Cysts

China
BioRegen Biomedical (CHangzhou) Co., Ltd

Completed

The Efficacy of A New Crosslinked Hyaluronan Gel in Prevention of Intrauterine Adhesion

Intrauterine Adhesion
Cipla BioTec Pvt. Ltd.

Unknown

Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC

Non-Small Cell Lung Carcinoma
Oulu University Hospital
Kanta-Häme Central Hospital; Bioretec Ltd.

Completed

Treatment of Children's Forearm Shaft Fractures With Biodegradable Intramedullary Nailing, Compared With Elastic Stable Intramedullary Nailing

Fractures, Bone | Injury Arm

Finland
University of Salzburg
Biolitec Pharma Ltd.

Unknown

Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma

Non-curative Resectable Bile Duct Carcinoma

Austria, Germany
Pharma Power Biotec Co., Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of Radion™-Pdt in Patients With Oral Precancerous Lesion

Erythroleukoplakia of Mouth | Verrucous Hyperplasia of Oral Mucosa

Taiwan
Pharma Power Biotec Co., Ltd.

Completed

A Study to Evaluate the Blood Glucose Regulation and Safety of PPB-R-203-02 Based Noodle Versus Commercially Available Wet Noodle in Patients With Diabetes

Diabetes Mellitus

Taiwan
Pharma Power Biotec Co., Ltd.

Unknown

A Study to Evaluate the Efficacy and Safety of PPB-R-203-Based Meal Versus TK9-Based Meal in 20 Patients With Diabetes

Diabetes Mellitus

Taiwan
Xiaozheng Shu

Completed

Efficacy and Safety of Crosslinked Hyaluronan Gel for Preventing Intrauterine Adhesion

Intrauterine Adhesion

China
Cipla BioTec Pvt. Ltd.
Quintiles, Inc.

Unknown

PK Bioequivalence Single-dose Safety Tolerability Study in Healthy Male Volunteers to Compare CBT124 & Avastin(EU&US) (CBT124NHV001)

Healthy

New Zealand
Biovotec AS

Completed

DermaRep™ Device in the Treatment of Venous Leg Ulcers (DermaRep™)

Venous Leg Ulcer

United Kingdom
Sengkang General Hospital
Biolitec

Recruiting

RCT Comparing Conventional Haemorrhoidectomy With Laser Haemorrhoidoplasty (COHLAH)

Hemorrhoids

Singapore
be Medical
Biolitec AG

Completed

Treatment of Varicose Veins With the ELVeS® Radial® 2ring Slim Fiber. Are There Limitations?

Varicose Veins

Belgium
Biotec Pharmacon ASA

Completed

Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers

Diabetes | Diabetic Ulcer

Spain
Biotec Pharmacon ASA

Completed

Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers

Chronic Diabetic Foot Ulcers

United Kingdom
Biotec Pharmacon ASA

Completed

The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients

Oral Mucositis

Germany, United Kingdom
Biotec Pharmacon ASA

Completed

Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients

Foot Ulcer

Russian Federation
Biotec Pharmacon ASA

Completed

Evaluation of Woulgan in Diabetic Foot Ulcer

Diabetic Foot Ulcers

United Kingdom, Sweden
Biotec Pharmacon ASA

Completed

Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy

Head and Neck Cancer | Oral Mucositis

France
Biotec Pharmacon ASA

Completed

Effect of SBG in Patients With Breast Cancer

Breast Cancer

Norway
Biotec Pharmacon ASA

Completed

Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

Norway
Biotec Pharmacon ASA

Terminated

Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns

Burns

Norway
Roswell Park Cancer Institute
National Institutes of Health (NIH); Biolitec Pharma Ltd.

Withdrawn

Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer

Tongue Cancer | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx | Recurrent Verrucous Carcinoma of the Oral Cavity | Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage I Squamous Cell Carcinoma of the Oropharynx and other conditions
Miltenyi Biotec, Inc.

Terminated

Stem Cell Implantation in Patients Undergoing CABG

Coronary Artery Disease | Ischemic Cardiomyopathy

United States
University of Arkansas
Erasmus Medical Center; The Netherlands Cancer Institute; Biolitec Pharma Ltd.

Terminated

Interstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck Cancers

Squamous Cell Carcinoma of the Head and Neck

United States
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.

Active, not recruiting

A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated (COVID-19)

Covid19

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.

Completed

Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above (COVID-19)

COVID-19 | COVID-19 Pneumonia

United Arab Emirates
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.

Active, not recruiting

A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTaP)

Whooping Cough | Tetanus | Diphtheria

China
Excited States, LLC
Veristat, Inc.; Eurofins; Biotec Services International Ltd; CBR International...

Completed

Study to Evaluate Efficacy and Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal Surgery (Triple IN)

Infections

United States, Israel
Sinopharm Wuhan Plasma-derived Biotherapies Co....
China National Biotec Group Company Limited; Beijing Tiantan Biological Products...

Not yet recruiting

Human COVID-19 Immunoglobulin (COVID-HIG) Therapy for COVID-19 Patients

COVID-19

United Arab Emirates
Zhejiang Provincial Center for Disease Control...
China National Biotec Group Company ltd

Completed

Immunogenicity and Safety of the Booster Dose of Polio Vaccine With Different Primary Sequential Schedules in China

Vaccine Reaction | Polio

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Shulan (Hangzhou) Hospital

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above (COVID-19)

COVID-19

China
Hospital Israelita Albert Einstein
Miltenyi Biotec, Inc.

Not yet recruiting

A Phase I Clinical Trial Using Genetically Engineered Autologous T Cells to Express Chimeric Antigen Receptor (CAR) for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies (CARTHIAE-1)

Acute Lymphoblastic Leukemia, in Relapse | B-cell Lymphoma Refractory | B-cell Lymphoma Recurrent | Chronic Lymphocytic Leukemia Recurrent | Chronic Lymphocytic Leukemia Refractory | Acute Lymphoblastic Leukemia Refractory

Brazil
University Health Network, Toronto
Miltenyi Biotec, Inc.

Completed

IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting (IMPACT-CABG)

Heart Failure | Coronary Artery Bypass Surgery | Heart Attack

Canada
China National Biotec Group Company Limited
The University of Hong Kong; Beijing Institute of Biological Products Co Ltd.; Wuhan Institute of Biological Products Co., Ltd

Active, not recruiting

Sequential Immunization of Two Doses of Inactivated COVID-19 Vaccine (Omicron) in Vaccinated Population Aged 18 Years and Above (COVID-19)

COVID-19

Hong Kong
University of Alabama at Birmingham
Miltenyi Biotec, Inc.

Active, not recruiting

Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors

Hematopoietic Stem Cell Transplantation

United States
Joanne Kurtzberg, MD
Duke University; Miltenyi Biotec, Inc.

Available

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

Hematologic Malignancies | Immune Deficiencies | Inborn Errors of Metabolism Disorders

United States

Clinical Trials Sponsored by Bioretec Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations